← Back to CVKD

Cadrenal Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 10/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 10/11/2025Jun 2024Filed 11/08/2025Mar 2024Filed 08/05/2025
−$3.3−$2.5−$2.7−$3.7−$3.8−$2.4−$2.4−$1.7
−$1.14−$1.04−$1.31−$1.87−$2.09−$2.18−$2.24−$1.56
2.92.4221.81.11.11.1

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.